Clinical trials
Imaging clinical trials
Below are recruiting imaging clinical trials, each written for real people, not researchers. We’re tracking 2,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06368817RecruitingPhase 2
Lower radiation dose for children with CNS germinoma
This trial will see if giving a lower dose of radiation therapy can still effectively treat children and young adults with a type of brain tumor called germinoma. The goal is to reduce side effects while keeping the cancer under control.
Mobile, AlabamaAges 3–29 - NCT06364410RecruitingPhase 1
Testing a new drug combo for stomach and other solid tumors
This trial tests a combination of two drugs, trastuzumab deruxtecan and azenosertib, for people with stomach cancer or other solid tumors that have a specific protein called HER2. It aims to see if this combination can help when other treatments have stopped working.
Houston, TexasAges 18 years+ - NCT06271785Recruiting
Predicting success of epilepsy surgery in children
This study uses a special, detailed brain-mapping technique (called high-resolution electrical source imaging) to see how well it can predict success after epilepsy surgery in children. It aims to help doctors decide which children might benefit most from surgery.
AngersAges 2–17 - NCT06369831RecruitingPhase 2
Imaging test for HER2 in metastatic cancer
This trial uses a special imaging scan to see if your cancer has HER2 on its surface, which could help decide if HER2-targeted treatment might work for you. It's for people with metastatic breast cancer or other solid tumors that have spread.
Innsbruck, TyrolAges 18 years+ - NCT06376500Recruiting
Brain stimulation to help thinking after concussion
This study tests whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) can help improve thinking and memory problems that some people have after a mild concussion. tDCS uses a small electrical current from scalp electrodes to gently activate parts of the brain.
Hung Hom, KowloonAges 18–65 - NCT06361498Recruiting
Ultrasound to check G-tube position in children
This study tests if ultrasound can quickly and safely check the position of a G-tube (feeding tube) that has moved or come out. It looks for a possible alternative to X-rays for children.
Chapel Hill, North CarolinaAges Up to 18 years - NCT06377371RecruitingPhase 4
Intraoperative tracing of meningioma with copper-64 DOTATATE
This trial tests a special imaging agent called [Cu64]DOTATATE that helps surgeons see meningioma tumors during surgery. It may make tumor removal more complete and safer.
New York, New YorkAges 18–99 - NCT06371404Recruiting
Brain imaging study of stress and alcohol use disorders
This study uses a special brain scan to look at how stress and alcohol use affect the brain. It may help people with PTSD, alcohol use disorder, or healthy volunteers understand these conditions better.
New Haven, ConnecticutAges 18–70 - NCT06377553Enrolling by invitation
PET/MRI scan for endometriosis diagnosis
This study uses a combined PET/MRI scan to better see endometriosis in people who are already scheduled for laparoscopic surgery. It may help find spots of endometriosis that are hard to see with other tests.
Charlestown, MassachusettsAges 18–70 - NCT06372730Recruiting
Predicting blood clot return after stopping blood thinners
This study uses a special 3D lung scan (V/Q SPECT/CT) to see if leftover blockages in your lungs can predict if another blood clot will come back. You may be eligible if your doctor has decided it's safe to stop your blood thinners after 3 to 6 months of treatment for a first blood clot.
Amiens, FranceAges 18 years+ - NCT06343844Recruiting
Heart attack recovery differences between men and women
This study looks at how men and women recover differently after a first heart attack. By comparing heart function over time, researchers hope to find better ways to treat each gender.
AngersAges 18 years+ - NCT05697406RecruitingPhase 1/Phase 2
Uses MRI to study tumors in people with cancer
This early study tests how well MRI (a type of scan) can help measure a substance related to tumors. If you already have cancer and are able to have an MRI scan, you may be able to take part.
Baltimore, MarylandAges 18–88 - NCT05324332Recruiting
Two scans to study prostate cancer in the same group
This trial looks at prostate cancer patients who have not started treatment yet and have two different PET/CT scans close together. It may help doctors compare how these scans show prostate cancer in the body.
Beijing, Beijing MunicipalityAges 18–90 - NCT06345508Recruiting
Finding liver cancer early with ultrasound
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
Montreal, QuebecAges 18 years+ - NCT06355713Recruiting
Symptom improvement after Essure implant removal
This study looks at women who are having symptoms from their Essure contraceptive implant and want it removed. It will measure how their symptoms improve after removal and may also include a special brain scan (MRI-PET) to check for changes.
AngersAges 35–75 - NCT06355778Recruiting
Brain and Opioid Use Study
This study uses brain scans to understand how adversity affects opioid use and recovery. It compares people with opioid use disorder on buprenorphine, people taking buprenorphine for chronic pain, and healthy volunteers.
Ann Arbor, MichiganAges 18–55 - NCT06353321Recruiting
PSMA-PET imaging for guiding radiation therapy in prostate cancer
This study tests a new way to use a PSMA-PET scan (a special imaging test that finds prostate cancer cells) to guide a type of radiation treatment called BgRT. It is for men with prostate cancer who are already getting a PSMA-PET scan as part of their regular care.
Dallas, TexasAges Any age - NCT06349512Recruiting
PET scan to predict treatment response in triple-negative breast cancer
This trial uses a special PET scan (68Ga-FAPI-46) to see if it can predict how well chemotherapy plus immunotherapy (pembrolizumab) works in people with triple-negative breast cancer before surgery. It aims to help doctors understand if the treatment is effective earlier.
AntonyAges 18 years+ - NCT06343831Recruiting
Measuring fat transfer results for breast reconstruction
This trial uses MRI scans to measure how well a patient's own fat stays after breast or chest wall reconstruction. The goal is to improve our understanding of fat transfer procedures.
Chicago, IllinoisAges 18 years+ - NCT06357676RecruitingPhase 1/Phase 2
Glofitamab, Ibrutinib and Obinutuzumab for Untreated Mantle Cell Lymphoma
This trial tests a combination of three drugs (glofitamab, ibrutinib, and obinutuzumab) for people with untreated mantle cell lymphoma. The goal is to see if this combination works better for high-risk or older patients.
Portland, OregonAges 18 years+ - NCT06344143Recruiting
Detecting mild hormone overproduction from adrenal tumors
This study looks for a mild form of hormone overproduction (called autonomous cortisol secretion) in people who have a benign growth on their adrenal gland. You will undergo a blood test to measure how well your body suppresses cortisol after taking a single dose of dexamethasone.
Cleveland, OhioAges 18 years+ - NCT06351345RecruitingPhase 2
Xenon imaging study for pulmonary hypertension patients on sotatercept
This trial uses a special imaging technique (xenon MRI) to see how well the lungs are functioning in people with pulmonary arterial hypertension (PAH) who are being treated with the drug sotatercept. It aims to understand if the drug improves lung function.
Durham, North CarolinaAges 18–75 - NCT06319027RecruitingPhase 2
Can brain scans help predict glioblastoma progression?
This trial is testing whether certain details on brain scans can help doctors better predict how brain cancer (glioblastoma) will progress. You may be eligible if you are newly diagnosed with this type of cancer and plan to receive standard treatment.
Birmingham, AlabamaAges 18 years+ - NCT06323109Recruiting
MRI scan to study prostate and urinary symptoms
This study uses MRI scans to look at the prostate and bladder in people with or without lower urinary tract symptoms (like trouble peeing). The goal is to see if MRI can help doctors better understand these symptoms and guide treatment.
Madison, WisconsinAges 18–80
Hear when a new Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for imaging?
- Yes. Clin2 currently lists 2,164 recruiting imaging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a imaging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a imaging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.